Cargando…

Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes

INTRODUCTION: The impaired host defense system in HIV infection impacts the oral and gastrointestinal microbiota and associated opportunistic infections. Antiretroviral treatment is predicted to partially restore host defenses and decrease the oral manifestation of HIV/AIDS. Well-designed longitudin...

Descripción completa

Detalles Bibliográficos
Autores principales: Phelan, Joan A., Abrams, William R., Norman, Robert G., Li, Yihong, Laverty, Maura, Corby, Patricia M., Nembhard, Jason, Neri, Dinah, Barber, Cheryl A., Aberg, Judith A., Fisch, Gene S., Poles, Michael A., Malamud, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237510/
https://www.ncbi.nlm.nih.gov/pubmed/25409430
http://dx.doi.org/10.1371/journal.pone.0112901
_version_ 1782345365229404160
author Phelan, Joan A.
Abrams, William R.
Norman, Robert G.
Li, Yihong
Laverty, Maura
Corby, Patricia M.
Nembhard, Jason
Neri, Dinah
Barber, Cheryl A.
Aberg, Judith A.
Fisch, Gene S.
Poles, Michael A.
Malamud, Daniel
author_facet Phelan, Joan A.
Abrams, William R.
Norman, Robert G.
Li, Yihong
Laverty, Maura
Corby, Patricia M.
Nembhard, Jason
Neri, Dinah
Barber, Cheryl A.
Aberg, Judith A.
Fisch, Gene S.
Poles, Michael A.
Malamud, Daniel
author_sort Phelan, Joan A.
collection PubMed
description INTRODUCTION: The impaired host defense system in HIV infection impacts the oral and gastrointestinal microbiota and associated opportunistic infections. Antiretroviral treatment is predicted to partially restore host defenses and decrease the oral manifestation of HIV/AIDS. Well-designed longitudinal studies are needed to better understand the interactions of soluble host defense proteins with bacteria and virus in HIV/AIDS. “Crosstalk” was designed as a longitudinal study of host responses along the gastrointestinal (GI) tract and interactions between defense molecules and bacteria in HIV infection and subsequent therapy. PURPOSE: The clinical core formed the infrastructure for the study of the interactions between the proteome, microbiome and innate immune system. The core recruited and retained study subjects, scheduled visits, obtained demographic and medical data, assessed oral health status, collected samples, and guided analysis of the hypotheses. This manuscript presents a well-designed clinical core that may serve as a model for studies that combine clinical and laboratory data. METHODS: Crosstalk was a case-control longitudinal clinical study an initial planned enrollment of 170 subjects. HIV+ antiretroviral naïve subjects were followed for 9 visits over 96 weeks and HIV uninfected subjects for 3 visits over 24 weeks. Clinical prevalence of oral mucosal lesions, dental caries and periodontal disease were assessed. RESULTS: During the study, 116 subjects (47 HIV+, 69 HIV-) were enrolled. Cohorts of HIV+ and HIV- were demographically similar except for a larger proportion of women in the HIV- group. The most prevalent oral mucosal lesions were oral candidiasis and hairy leukoplakia in the HIV+ group. DISCUSSION: The clinical core was essential to enable the links between clinical and laboratory data. The study aims to determine specific differences between oral and GI tissues that account for unique patterns of opportunistic infections and to delineate the differences in their susceptibility to infection by HIV and their responses post-HAART.
format Online
Article
Text
id pubmed-4237510
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42375102014-11-21 Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes Phelan, Joan A. Abrams, William R. Norman, Robert G. Li, Yihong Laverty, Maura Corby, Patricia M. Nembhard, Jason Neri, Dinah Barber, Cheryl A. Aberg, Judith A. Fisch, Gene S. Poles, Michael A. Malamud, Daniel PLoS One Research Article INTRODUCTION: The impaired host defense system in HIV infection impacts the oral and gastrointestinal microbiota and associated opportunistic infections. Antiretroviral treatment is predicted to partially restore host defenses and decrease the oral manifestation of HIV/AIDS. Well-designed longitudinal studies are needed to better understand the interactions of soluble host defense proteins with bacteria and virus in HIV/AIDS. “Crosstalk” was designed as a longitudinal study of host responses along the gastrointestinal (GI) tract and interactions between defense molecules and bacteria in HIV infection and subsequent therapy. PURPOSE: The clinical core formed the infrastructure for the study of the interactions between the proteome, microbiome and innate immune system. The core recruited and retained study subjects, scheduled visits, obtained demographic and medical data, assessed oral health status, collected samples, and guided analysis of the hypotheses. This manuscript presents a well-designed clinical core that may serve as a model for studies that combine clinical and laboratory data. METHODS: Crosstalk was a case-control longitudinal clinical study an initial planned enrollment of 170 subjects. HIV+ antiretroviral naïve subjects were followed for 9 visits over 96 weeks and HIV uninfected subjects for 3 visits over 24 weeks. Clinical prevalence of oral mucosal lesions, dental caries and periodontal disease were assessed. RESULTS: During the study, 116 subjects (47 HIV+, 69 HIV-) were enrolled. Cohorts of HIV+ and HIV- were demographically similar except for a larger proportion of women in the HIV- group. The most prevalent oral mucosal lesions were oral candidiasis and hairy leukoplakia in the HIV+ group. DISCUSSION: The clinical core was essential to enable the links between clinical and laboratory data. The study aims to determine specific differences between oral and GI tissues that account for unique patterns of opportunistic infections and to delineate the differences in their susceptibility to infection by HIV and their responses post-HAART. Public Library of Science 2014-11-19 /pmc/articles/PMC4237510/ /pubmed/25409430 http://dx.doi.org/10.1371/journal.pone.0112901 Text en © 2014 Phelan et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Phelan, Joan A.
Abrams, William R.
Norman, Robert G.
Li, Yihong
Laverty, Maura
Corby, Patricia M.
Nembhard, Jason
Neri, Dinah
Barber, Cheryl A.
Aberg, Judith A.
Fisch, Gene S.
Poles, Michael A.
Malamud, Daniel
Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes
title Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes
title_full Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes
title_fullStr Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes
title_full_unstemmed Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes
title_short Design Aspects of a Case-Control Clinical Investigation of the Effect of HIV on Oral and Gastrointestinal Soluble Innate Factors and Microbes
title_sort design aspects of a case-control clinical investigation of the effect of hiv on oral and gastrointestinal soluble innate factors and microbes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237510/
https://www.ncbi.nlm.nih.gov/pubmed/25409430
http://dx.doi.org/10.1371/journal.pone.0112901
work_keys_str_mv AT phelanjoana designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT abramswilliamr designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT normanrobertg designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT liyihong designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT lavertymaura designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT corbypatriciam designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT nembhardjason designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT neridinah designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT barbercheryla designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT abergjuditha designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT fischgenes designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT polesmichaela designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes
AT malamuddaniel designaspectsofacasecontrolclinicalinvestigationoftheeffectofhivonoralandgastrointestinalsolubleinnatefactorsandmicrobes